Your browser doesn't support javascript.
loading
Linguistic Validation of the Phenylketonuria - Quality of Life (PKU-QOL) Questionnaire Into Brazilian Portuguese
Vicente, Fabíola; Jurecki, Elaina; Giovannetti, Daniela; Ferreira, Ana Rita; Leite, Efigênia; Giugliani, Luciana; Acquadro, Catherine.
  • Vicente, Fabíola; BioMarin Brasil Farmacêutica Ltda.. São Paulo. BR
  • Jurecki, Elaina; BioMarin Pharmaceutical Inc.. San Rafael. US
  • Giovannetti, Daniela; BioMarin Brasil Farmacêutica Ltda.. São Paulo. BR
  • Ferreira, Ana Rita; APAE São Paulo. São Paulo. BR
  • Leite, Efigênia; APAE Salvador. Salvador. BR
  • Giugliani, Luciana; Hospital de Clínicas de Porto Alegre. Porto Alegre. BR
  • Acquadro, Catherine; Mapi, an ICON plc Company. Patient-Centered Services. Lyon. FR
J. inborn errors metab. screen ; 7: e20180001, 2019. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1090975
ABSTRACT
Abstract The phenylketonuria - quality of life (PKU-QOL) questionnaire was developed to assess the impact of phenylketonuria (PKU) and its treatment on the health-related quality of life (HRQL) of patients and their caregivers. Available in four versions (child, adolescent, adult and parent), it was developed and validated in eight countries. The objective of this study was to linguistically validate the PKU-QOL questionnaire in Brazilian Portuguese for use in Brazil by clinicians who take care of PKU patients. The translation method used a standard linguistic validation process. The British English version served as a basis for translation. No major cultural or semantic issues were found during the process. The main difficulty was the use of the acronym "PKU" in the first translations. During the cognitive interviews, respondents made the confusion between the disease itself and the food supplement since it is written "PKU" or "COMIDA-PKU" on the packaging of the product. To overcome this issue, it was decided to use fenilcetonuria (fenil) or fenil alone throughout all versions. The PKU-QOL will be valuable for Brazilian healthcare providers in individualizing treatment and managing patients with PKU.


Full text: Available Index: LILACS (Americas) Country/Region as subject: South America / Brazil Language: English Journal: J. inborn errors metab. screen Journal subject: Medicina Cl¡nica / Patologia Year: 2019 Type: Article Affiliation country: Brazil / France / United States Institution/Affiliation country: APAE Salvador/BR / APAE São Paulo/BR / BioMarin Brasil Farmacêutica Ltda./BR / BioMarin Pharmaceutical Inc./US / Hospital de Clínicas de Porto Alegre/BR / Mapi, an ICON plc Company/FR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Country/Region as subject: South America / Brazil Language: English Journal: J. inborn errors metab. screen Journal subject: Medicina Cl¡nica / Patologia Year: 2019 Type: Article Affiliation country: Brazil / France / United States Institution/Affiliation country: APAE Salvador/BR / APAE São Paulo/BR / BioMarin Brasil Farmacêutica Ltda./BR / BioMarin Pharmaceutical Inc./US / Hospital de Clínicas de Porto Alegre/BR / Mapi, an ICON plc Company/FR